MWNA
PVLA

Marshall Wace North America’s Palvella Therapeutics PVLA Stock Holding History

Marshall Wace North America’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4.51M Buy
+10,895
New +$3.79M 0.02% 539
2020
Q1 		– Sell
-2,422
Closed -$701K – 1656
2019
Q4 		$701K Buy
+2,422
New +$671K ﹤0.01% 772
2018
Q3 		– Sell
-2,011
Closed -$816K – 1431
2018
Q2 		$816K Sell
2,011
-2,473
-55% -$1.18M ﹤0.01% 985
2018
Q1 		$2.45M Buy
+4,484
New +$2.78M 0.01% 756
2017
Q4 		– Sell
-214
Closed -$103K – 1651
2017
Q3 		$103K Buy
+214
New +$91.4K ﹤0.01% 1202

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $37.1M AUM 41.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return